Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Novo Nordisk
Novo Nordisk
Investing
Novo Nordisk stock trades at 4-year-low on the back of disappointing Alzheimer’s trial
By
Nick Lichtenberg
November 24, 2025
Health
Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic
By
Nick Lichtenberg
November 6, 2025
Future of Work
From retail to tech, here are the 10 corporations that recently announced mass layoffs
By
Wyatte Grantham-Philips
and
The Associated Press
October 28, 2025
Investing
Novo chairman to step down in board rift over pace of change
By
Deirdre Hipwell
,
Maddie Parker
and
Bloomberg
October 21, 2025
North America
Newman’s Own and Novo Nordisk have funded a program of Gen Z Native Americans who are fighting tribal food insecurity
By
James Pollard
and
The Associated Press
October 13, 2025
Health
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
By
Nick Lichtenberg
August 18, 2025
C-Suite
Novo Nordisk selects insider Maziar Mike Doustdar as new CEO, to tackle ‘recent market challenges’
By
AFP
July 29, 2025
Health
Novo Nordisk overtakes SAP as Europe’s most valuable company
By
Lisa Pham
and
Bloomberg
June 13, 2025
Health
The Ozempic boom could be bad news for restaurants as more than half of GLP-1 users report cutting back on dining out, report finds
By
Sasha Rogelberg
June 4, 2025
Finance
Ozempic CEO’s exit from Novo started with Teams call surprise
By
Naomi Kresge
and
Bloomberg
May 16, 2025
Tech
Novo ousts CEO Jorgensen after Lilly competition hits shares
By
Eric Pfanner
and
Bloomberg
May 16, 2025
Health
Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
By
Jonel Aleccia
and
The Associated Press
May 12, 2025
Health
Currency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars
By
Ryan Hogg
May 9, 2025
Health
CVS strikes a deal to offer Wegovy at a discount
By
Chris Morris
May 1, 2025
Retail
Novo Nordisk slides on pressure from Lilly’s pill study
By
Marthe Fourcade
and
Bloomberg
April 22, 2025
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
Success
As millions of Gen Zers face unemployment, McDonald's CEO dishes out some tough love career...
By
Preston Fore
AI
'Robots are going to be amongst us': Qualcomm exec says buckle up for the next 5 years. Your car is going to be the...
By
Nino Paoli